Neos Therapeutics, Inc.
(NASDAQ GS: NEOS)
Rigrodsky Law, P.A. is investigating Neos Therapeutics, Inc. ("Neos”) regarding possible breaches of fiduciary duties and other violations of law related to Neos' agreement to be acquired by Aytu BioScience, Inc. ("Aytu"). Under the terms of the agreement, Neos' shareholders will receive 0.1088 shares of Aytu common stock per share.